We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $1.85M
1-Year Est. Return 176.16%
This Fund
S&P 500
This Quarter Est. Return
+26.83%
1 Year Est. Return
+176.16%
3 Year Est. Return
+511.75%
5 Year Est. Return
+854.95%
10 Year Est. Return
+8,566.11%
AUM
$39.1M
AUM Growth
-$14M
Cap. Flow
-$401K
Cap. Flow %
-1.02%
Top 10 Hldgs %
95.65%
Holding
22
New
5
Increased
2
Reduced
1
Closed
5

Top Buys

Rank Stock Value
1
CMPX icon
Compass Therapeutics
CMPX
+$842K
2
CABA icon
Cabaletta Bio
CABA
+$308K
3
ALLK
Allakos
ALLK
+$127K
4
VECT
VectivBio Holding AG Ordinary Shares
VECT
+$124K
5
NAMSW icon
NewAmsterdam Pharma Warrant
NAMSW
+$17.6K

Top Sells

Rank Stock Value
1
ACLX
Arcellx
ACLX
+$915K
2
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$880K
3
FLACW
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
+$17K
4
LUXAW
Lux Health Tech Acquisition Corp. Warrants
LUXAW
+$9K
5
PV.WS
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
+$2K

Sector Composition

Rank Sector Weight
1 Healthcare 75.41%
2 Miscellaneous 24.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SVRA icon
1
Savara
SVRA
$1.1B
$10.7M 27.3%
6,896,551
– –
XERS icon
2
Xeris Biopharma Holdings
XERS
$1.56B
$8.03M 20.52%
6,039,028
– –
SPY icon
3
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$6.1M 15.58%
15,947
– –
RZLT icon
4
Rezolute
RZLT
$441M
$2.9M 7.42%
1,403,157
– –
SCYX icon
5
SCYNEXIS
SCYX
$52.7M
$2.69M 6.87%
215,493
– –
XOP icon
6
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4.06B
$2.38M 6.07%
17,500
– –
VECT
7
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$1.35M 3.44%
156,222
+15,359
+11% +$124K
ACLX
8
DELISTED
Arcellx
ACLX
$1.12M 2.87%
36,302
-39,884
-52% -$915K
AMLP icon
9
Alerian MLP ETF
AMLP
$13.5B
$1.12M 2.87%
29,500
– –
CMPX icon
10
Compass Therapeutics
CMPX
$429M
$1.06M 2.71%
+211,159
New +$842K
CABA icon
11
Cabaletta Bio
CABA
$588M
$784K 2%
+84,728
New +$308K
MTEM
12
DELISTED
Molecular Templates, Inc.
MTEM
$673K 1.72%
136,866
– –
ALLK
13
DELISTED
Allakos
ALLK
$154K 0.39%
+18,271
New +$127K
ELEV
14
DELISTED
Elevation Oncology
ELEV
$64.8K 0.17%
68,324
+27
+0% +$27
NAMSW icon
15
NewAmsterdam Pharma Warrant
NAMSW
$63.8M
$17.8K 0.05%
+21,333
New +$17.6K
BTWNW
16
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$4.67K 0.01%
39,773
– –
LANV.WS
17
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$3.78K 0.01%
+12,000
New +$3.15K
USO icon
18
CALL
United States Oil Fund
USO
$1.95B
– –
-173,500
Closed -$11.3M
EIGR
19
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-3,896
Closed -$880K
PV.WS
20
DELISTED
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
– –
-12,000
Closed -$2K
FLACW
21
DELISTED
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
– –
-21,333
Closed -$17K
LUXAW
22
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
– –
-66,666
Closed -$9K

Similar funds

1IC
1922 Investment Company Houston, Texas $1.89M AUM 15.39% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $1.91M AUM 81.42% 1-Year Est. Return
HGCK
HPC Germany & Co KG Potsdam, Germany $1.68M AUM 15.3% 1-Year Est. Return
CA
Cohalo Advisory Snoqualmie, Washington $1.65M AUM 11.44% 1-Year Est. Return
CAM
Creekmur Asset Management Morton, Illinois $2.07M AUM
FLC
Fifth Lane Capital Austin, Texas $1.63M AUM 7.3% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $1.56M AUM 25.68% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

Caxton Corporation's Q4 2022 Portfolio in Review

As of Q4 2022, Caxton Corporation held 22 positions worth $39.1M, down 26% from $53.2M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Caxton Corporation's Q4 2022 filing shows 5 new, 2 increased, 1 reduced and 5 closed positions. Its largest new stake was Compass Therapeutics: 211,159 shares worth $1.06M. The largest sale was Arcellx, an estimated $915K.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, up from 62% a quarter earlier, followed by Miscellaneous.

  • Caxton Corporation's largest Q4 2022 buy was Compass Therapeutics: 211,159 shares worth $1.06M.
  • Caxton Corporation added most to VectivBio Holding AG Ordinary Shares in Q4 2022, an estimated $124K increase.
  • Caxton Corporation's biggest Q4 2022 reduction was Arcellx, cutting an estimated $915K.
  • Caxton Corporation fully exited Eiger BioPharmaceuticals, Inc. in Q4 2022, selling an estimated $880K.
  • Caxton Corporation's ten largest holdings make up 96% of its $39.1M portfolio in Q4 2022.
  • Caxton Corporation opened 5 new positions and closed 5 in Q4 2022.
  • Caxton Corporation's portfolio value fell 26% quarter-over-quarter to $39.1M.

Based on Caxton Corporation's 13F filing for Q4 2022, filed 14 Feb 2023.